REAL WORLD ADHERENCE, PERSISTENCE, RELAPSE AND MULTIPLE SCLEROSIS SYMPTOMS AMONG PATIENTS TREATED WITH ORAL DISEASE-MODIFYING THERAPIES

被引：0
|
作者：
Leist, T. [1 ]
Le, H. [2 ]
Verma, S. [3 ]
Cole, M. [4 ]
Afolabi, M. [3 ]
Tsai, W. L. [3 ]
Keenan, A. [5 ]
机构：
[1] Jefferson Univ, Philadelphia, PA USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] STATinMED Res Inc, Plano, TX USA
[4] Janssen Global Serv LLC, Southampton, PA USA
[5] Janssen Global Serv LLC, Titusville, NJ USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PB3
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [21] Adherence to disease-modifying therapies and attitudes regarding disease in patients with multiple sclerosis
    Ozura, Ana
    Kovac, Lea
    Sega, Sasa
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S6 - S11
  • [22] Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis
    Zuckerman, Autumn D.
    DeClercq, Josh
    Simonson, Dana
    Zagel, Alicia L.
    Turco, Evan
    Banks, Aimee
    Wawrzyniak, Julie
    Rightmier, Elizabeth
    Blevins, Abbi
    Choi, Leena
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
  • [23] Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosis
    Lafata, Jennifer Elston
    Cerghet, Mirela
    Dobie, Elizabeth
    Schultz, Lonni
    Tunceli, Kaan
    Reuther, Jacqueline
    Elias, Stanton
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2008, 48 (06) : 752 - 757
  • [24] Impact of adherence to disease-modifying therapies on employment among veterans with multiple sclerosis
    Rabadi, Meheroz H.
    Just, Kimberly
    Xu, Chao
    DISABILITY AND REHABILITATION, 2022, 44 (16) : 4415 - 4420
  • [25] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    Qian Cai
    Sonalee Agarwal
    Judith J. Stephenson
    Siddhesh Kamat
    Advances in Therapy, 2011, 28 : 51 - 61
  • [26] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Tan, Hiangkiat
    Cai, Qian
    Agarwal, Sonalee
    Stephenson, Judith J.
    Kamat, Siddhesh
    ADVANCES IN THERAPY, 2011, 28 (01) : 51 - 61
  • [27] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Kretzschmar, Benedikt
    Pellkofer, Hannah
    Weber, Martin S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04)
  • [28] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    Current Neurology and Neuroscience Reports, 2016, 16
  • [29] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [30] Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
    Melesse, Dessalegn Y.
    Marrie, Ruth Ann
    Blanchard, James F.
    Yu, Bo Nancy
    Evans, Charity
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1093 - 1101
12345